1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7078)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22470)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10530)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (298)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22470)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Heterodimeric bispecific antibodies for highly specific treatment of EGFR(+)HER2(+) pancreatic ductal adenocarcinoma
    Meeting Abstract

    Long, A. W.; Santich, B.; Guo, H.; Cheung, N. K.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic profiling identifies differences in the distribution of APC mutations in non-Hispanic black and non-Hispanic white patients with colorectal cancer
    Meeting Abstract

    Walch, H.; Luthra, A.; Chatila, W.; Arora, K.; Chin, S.; Waters, M.; Smith, J. J.; Schultz, N.; Berger, M. F.; Ganesh, K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Dissecting the reorganization of pancreatic tumor microenvironments after radiation and immunotherapy reveals insights into immunotherapy resistance
    Meeting Abstract

    Mehta, A.; Parikh, A.; Parikh, M.; Park, R.; Sade-Feldman, M.; Bi, L.; Carzo, N.; Grillo, T. M.; Baiev, I.; Asupoto, O.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype and promotes immune surveillance in PDAC
    Meeting Abstract

    Chibaya, L.; Murphy, K. C.; Diaz, Y. L.; DeMarco, K. D.; Liu, H.; Gopalan, S.; Faulkner, M.; Li, J.; Morris, J. P. 4th; Ho, Y. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Altered RNA splicing causes pancreatic cancer and exposes a therapeutic vulnerability
    Meeting Abstract

    Medici, N. P.; Saucedo, D. M.; Lee, D.; Ku, L. T.; Tseng, R.; Cannataro, V.; Yugawa, D.; Chowdhury, S.; Townsend, J.; Iacobuzio-Donahue, C. A.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Polymerase theta inhibition activates the cGAS-STING signaling pathway and elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma
    Meeting Abstract

    Oh, G.; Wang, A.; Wang, L.; Li, J.; Werba, G.; Weissinger, D.; Zhao, E.; Dhara, S.; Hernandez, R.; Ackermann, A.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeting pancreatic cancer senescence with ImmunoPET
    Meeting Abstract

    Pratt, E. C.; Mezzadra, R.; Viray, T.; Kaminsky, S.; Lowe, S. W.; Lewis, J. S.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Quantifying and dissecting pancreatic cancer cell phenotypic plasticity using lineage tracing, single-cell multiomics and CRISPR perturbations reveals novel regulators of plastic states
    Meeting Abstract

    Mehta, A.; Bi, L.; Al'Khafaji, A.; Jankowiak, M.; Parikh, M.; Babadi, M.; Bloemendal, A.; Schwartz, M.; Munson, G.; Chan, J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Microbial changes in response to a plant-based diet and/or supplements in SMM patients: A national multi-arm randomized prospective telehealth study via HealthTree: The nutrition prevention (NUTRIVENTION-2) study
    Meeting Abstract

    Castro, F.; Sweeney, N. W.; Derkach, A.; Traore, K.; Anuraj, A.; Guttentag, L.; Blaslov, J.; Sahagun, A.; Hydren, J.; Chmielewski, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A phase 1b study of IDH inhibition with enasidenib and MEK inhibition with cobimetinib in patients with relapsed or refractory acute myeloid leukemia who have co-occurring IDH2 and RAS signaling gene mutations
    Meeting Abstract

    Ball, B. J.; Stein, E.; Robbins, M.; Zhang, J.; Levine, R. L.; Synold, T.; Stein, A. S.; Marcucci, G.; Liu, Y.; Danilov, A. V.
    Blood (2022)

    Fulltext@MSK | Save